Characterising the knowledge, attitudes and practices of Australian veterinarians regarding Q fever and the diagnosis and reporting of coxiellosis.

Q fever is a serious zoonotic disease that readily transmits from animals to humans. Infection in animals is known as coxiellosis. Veterinarians are in a key position to provide early detection of coxiellosis in animals that can aid the prevention or recognition of human cases.

Tracking Persistent Symptoms in Scotland (TraPSS): a longitudinal prospective cohort study of COVID-19 recovery after mild acute infection.

Background: COVID-19 disease results in disparate responses between individuals and has led to the emergence of long coronavirus disease (Long-COVID), characterised by persistent and cyclical symptomology. To understand the complexity of Long-COVID, the importance of symptom surveillance and prospective longitudinal studies is evident.

Methods: A 9-month longitudinal prospective cohort study was conducted within Scotland (n=287), using a mobile app to determine the proportion of recovered individuals and those with persistent symptoms and common symptoms, and associations with gender and age.

Understanding how on-farm biosecurity perceptions and practices of New South Wales sheep producers have been impacted by the 2022 foot-and-mouth disease outbreak in Indonesia.

Foot-and-mouth disease (FMD) is a highly infectious transboundary emergency animal disease posing a significant threat to the global economy. Australia strengthened border security following the 2022 FMD outbreak in Indonesia allocating resources to promote biosecurity awareness and engagement. This study qualitatively investigated the impact of this extension on the biosecurity perceptions and practices of sheep producers in New South Wales, Australia.

Pro-cognitive reshaping of neuronal dynamics by a human CSF-based factor.

Neuronal connection dysfunction is a convergent cause of cognitive deficits in mental disorders. Cognitive processes are finely regulated at the synaptic level by membrane proteins, some of which are shed and detectable in patients' cerebrospinal fluid (CSF). However, whether these soluble synaptic proteins can harnessed as innovative pro-cognitive factors to treat brain disorders remains unclear.